PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 295,000
-8,500 (-2.80%)
Jun 16, 2026, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 3.06 trillion as of June 16, 2026. Its market cap has decreased by -32.95% in one year.
Market Cap
3.06T
Enterprise Value
2.68T
Revenue
565.48B
Ranking
n/a
PE Ratio
18.60
Stock Price
295,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.06T, an increase of 203.68%. That is a compound annual growth rate of 10.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 3.06T | -26.80% |
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.88T |
| HLB Co., Ltd. | 6.13T |
| Peptron | 5.36T |
| LigaChem Biosciences | 4.76T |
| D&D Pharmatech | 3.83T |
| Voronoi | 3.48T |
| SK bioscience | 3.08T |
| Hugel | 2.64T |